{"id":"https://openalex.org/W8713393","doi":"https://doi.org/10.1182/blood.v122.21.285.285","title":"Prolonged Survival and Improved Response Rates With ARRY-520 In Relapsed/Refractory Multiple Myeloma (RRMM) Patients With Low \u03b1-1 Acid Glycoprotein (AAG) Levels: Results From a Phase 2 Study","display_name":"Prolonged Survival and Improved Response Rates With ARRY-520 In Relapsed/Refractory Multiple Myeloma (RRMM) Patients With Low \u03b1-1 Acid Glycoprotein (AAG) Levels: Results From a Phase 2 Study","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W8713393","doi":"https://doi.org/10.1182/blood.v122.21.285.285","mag":"8713393"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.285.285","doi":"https://doi.org/10.1182/blood.v122.21.285.285","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.285.285","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023276777","display_name":"Sagar Lonial","orcid":"https://orcid.org/0000-0002-8322-9323","observed_orcids":["https://orcid.org/0000-0002-8322-9323"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sagar Lonial","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA, USA,","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108104588","display_name":"Jatin J. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jatin J. Shah","raw_affiliation_strings":["Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034791164","display_name":"Jeffrey A. Zonder","orcid":"https://orcid.org/0000-0002-1741-2795","observed_orcids":["https://orcid.org/0000-0002-1741-2795"]},"institutions":[{"id":"https://openalex.org/I185443292","display_name":"Wayne State University","ror":"https://ror.org/01070mq45","country_code":"US","type":"education","lineage":["https://openalex.org/I185443292"]},{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Zonder","raw_affiliation_strings":["Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karmanos Cancer Institute/Wayne State University, Detroit, MI, USA","institution_ids":["https://openalex.org/I185443292","https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113514827","display_name":"William Bensinger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William I. Bensinger","raw_affiliation_strings":["Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA,","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025168585","display_name":"Adam D. Cohen","orcid":"https://orcid.org/0000-0003-0939-3843","observed_orcids":["https://orcid.org/0000-0003-0939-3843"]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam D. Cohen","raw_affiliation_strings":["Fox Chase Cancer Center, Philadelphia, PA, USA,","Fox Chase Cancer Center,#R#Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fox Chase Cancer Center, Philadelphia, PA, USA,","institution_ids":["https://openalex.org/I1289437631"]},{"raw_affiliation_string":"Fox Chase Cancer Center,#R#Philadelphia, PA, USA","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077897003","display_name":"Jonathan L. Kaufman","orcid":"https://orcid.org/0000-0002-5687-6429","observed_orcids":["https://orcid.org/0000-0002-5687-6429"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan L. Kaufman","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA, USA,","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022520524","display_name":"Ajay K. Nooka","orcid":"https://orcid.org/0000-0003-4165-6869","observed_orcids":["https://orcid.org/0000-0003-4165-6869"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ajay K. Nooka","raw_affiliation_strings":["Winship Cancer Institute, Emory University, Atlanta, GA, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Winship Cancer Institute, Emory University, Atlanta, GA, USA,","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113916086","display_name":"Donna M. Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donna M. Weber","raw_affiliation_strings":["Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA,","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022683984","display_name":"Brandi W. Hilder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brandi Hilder","raw_affiliation_strings":["Array BioPharma, Boulder, CO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Array BioPharma, Boulder, CO, USA,","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020248787","display_name":"Selena Armistead Rush","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Selena A Rush","raw_affiliation_strings":["Array BioPharma Inc., Boulder, CO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Array BioPharma Inc., Boulder, CO, USA,","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009186424","display_name":"Ann Marie Ptaszynski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann Ptaszynski","raw_affiliation_strings":["Array Biopharma, Boulder, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Array Biopharma, Boulder, CO, USA","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114016505","display_name":"Duncan Walker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101899","display_name":"Array BioPharma (United States)","ror":"https://ror.org/018axtd57","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Duncan Walker","raw_affiliation_strings":["Array BioPharma, Boulder, CO, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Array BioPharma, Boulder, CO, USA,","institution_ids":["https://openalex.org/I4210101899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038235561","display_name":"Robert Zygmunt Orlowski","orcid":"https://orcid.org/0000-0002-5723-4129","observed_orcids":["https://orcid.org/0000-0002-5723-4129"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Z. Orlowski","raw_affiliation_strings":["Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center, Houston , TX , USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":4.7823,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.95070742,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"122","issue":"21","first_page":"285","last_page":"285"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9660000205039978},{"id":"https://openalex.org/keywords/alpha-1-acid-glycoprotein","display_name":"alpha-1-acid glycoprotein","score":0.8669999837875366},{"id":"https://openalex.org/keywords/acute-phase-proteins","display_name":"acute phase proteins","score":0.6919999718666077},{"id":"https://openalex.org/keywords/drug-binding","display_name":"drug binding","score":0.7039999961853027},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7820000052452087},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.5920000076293945},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.6959999799728394},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.39800000190734863}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7962232828140259},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.7448738813400269},{"id":"https://openalex.org/C2778524551","wikidata":"https://www.wikidata.org/wiki/Q7227206","display_name":"Pomalidomide","level":4,"score":0.6228857040405273},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5768005847930908},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5583912134170532},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5564346313476562},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5380451679229736},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5165950059890747},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.484479159116745},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.4584083557128906},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45723140239715576},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.44973883032798767},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.4467935860157013},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.43093743920326233},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4179285764694214},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3994160294532776},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3964555859565735},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.21899071335792542},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.285.285","doi":"https://doi.org/10.1182/blood.v122.21.285.285","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.285.285","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9907000064849854,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.8299999833106995,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2980259995","https://openalex.org/W2981010338","https://openalex.org/W2980385440","https://openalex.org/W2587993401","https://openalex.org/W93473583","https://openalex.org/W2527913164","https://openalex.org/W2261179005","https://openalex.org/W2569801315","https://openalex.org/W4246703220","https://openalex.org/W2944083662"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,63,91,336,381],"availability":[3],"of":[4,30,42,51,103,142,171,180,186,237,243,248,279,285,319,342,350,383,446,559,587,594,598,605,660,674,689,703,717,769,781,797,812,827,842,855],"multiple":[5,21],"immunomodulators":[6],"(IMiDs)":[7],"and":[8,36,101,112,148,188,194,240,256,282,306,362,366,370,374,376,379,392,400,478,541,546,570,582,608],"proteasome":[9],"inhibitors":[10],"(PIs)":[11],"has":[12,57,395,480],"resulted":[13],"in":[14,61,75,79,130,162,206,214,221,291,333,388,407,473,487,494,501,529,547,571,576],"improved":[15],"outcomes":[16],"for":[17],"patients":[18,504],"(pts)":[19],"with":[20,39,81,117,132,137,156,164,166,233,275,401,411,423,440,450,465,510,549,573,589,591,602,613],"myeloma":[22],"(MM).":[23],"Pts":[24,197],"refractory":[25,135,173,189,253,305,578],"to":[26,97,183,190,199,254,273,311,421,463,485,579,627],"these":[27],"2":[28,93,113,115,120,139,152,168,295,321,475,534],"classes":[29],"drugs":[31,38,590],"have":[32,122,230,270,414],"a":[33,47,87,234,241,276,283,308,329,433,453,482,512,524,538,585,603,619],"poor":[34],"prognosis":[35],"new":[37],"novel":[40,53,513,525,580],"mechanisms":[41,593],"action":[43],"are":[44,219,600],"needed.":[45],"ARRY-520,":[46,69,614],"potent,":[48],"selective":[49],"inhibitor":[50],"the":[52,99,222,292,427,502,557],"drug":[54],"target":[55],"KSP,":[56],"shown":[58,396,481],"single-agent":[59,128],"activity":[60,397,540,567],"MM.":[62,530],"acute-phase":[64],"protein":[65],"AAG":[66,210,413,452,467,599,616],"can":[67],"bind":[68],"reducing":[70],"free":[71],"drug,":[72],"possibly":[73],"resulting":[74],"reduced":[76],"treatment":[77,300,612],"effect":[78],"pts":[80,131,163,229,251,259,269,296,322,410,422,449,464,577,625],"high":[82,262,324],"AAG.":[83,264,326,425],"Methods":[84],"ARRAY-520-212":[85],"is":[86,476,523,555],"Phase":[88,92,533],"1/2":[89],"study.":[90],"portion":[94],"was":[95,386,460,562],"designed":[96],"evaluate":[98],"efficacy":[100],"safety":[102,331,542],"1.5":[104],"mg/m2/day":[105],"ARRY-520":[106,129,155,327,394,431,522,536,564,649],"administered":[107],"intravenously":[108],"on":[109,175,314,656,670,685,699,713,765,777,793,808,823,838,851],"Days":[110],"1":[111,126,250],"every":[114],"weeks":[116],"filgrastim":[118],"support.":[119],"Cohorts":[121],"been":[123,231,271],"enrolled:":[124],"Cohort":[125,151],"investigated":[127,154],"relapsed":[133],"or":[134,176,201,516,662,676,691,705,719,771,783,799,814,829,844,857],"MM":[136],"\u2265":[138,167],"prior":[140,169,245,287,299,315],"lines":[141,170],"therapy,":[143,172,187],"including":[144],"both":[145,215,334,389,398,408,544,568],"bortezomib":[146],"(BTZ)":[147],"an":[149,441,657,671,686,700,714,766,778,794,809,824,839,852],"IMiD.":[150],"(cohort2)":[153],"Low-dose":[157],"dexamethasone":[158,195],"(LoDex":[159],"-40mg":[160],"weekly)":[161],"RRMM":[165],"(progression":[174],"within":[177],"60":[178],"days":[179],"last":[181,184],"treatment)":[182],"line":[185],"BTZ,":[191],"lenalidomide":[192],"(Len)":[193],"(triple-refractory).":[196],"intolerant":[198],"Len":[200],"BTZ":[202,255],"were":[203,212,252,302,352,499,507],"not":[204],"included":[205],"cohort2.":[207],"Baseline":[208],"plasma":[209],"levels":[211,597],"measured":[213],"cohorts.":[216],"Results":[217,218],"summarized":[220],"attached":[223],"table.":[224],"In":[225,265,426,448,531],"cohort":[226,249,266,294,320,355,358,429,474,495],"1,":[227,356,430],"32":[228],"treated,":[232],"median":[235,242,277,284],"age":[236,278],"65":[238],"years":[239,281],"6":[244],"regimens.":[246,288],"41%":[247],"Len.":[257],"6/27":[258],"(22%)":[260],"had":[261,297,307,323,415],"baseline":[263,325],"2,":[267,496],"50":[268],"treated":[272,509],"date,":[274,406],"63":[280],"9":[286],"As":[289],"described":[290],"table,":[293],"more":[298],"regimens,":[301],"primarily":[303],"triple":[304],"short":[309],"time":[310],"progression":[312],"(TTP)":[313],"therapy.":[316],"13/44":[317],"(30%)":[318],"showed":[328,432,537,565],"similar":[330,539],"profile":[332,543],"Cohorts.":[335],"most":[337],"commonly":[338],"reported":[339],"(\u2265":[340],"10%":[341],"pts)":[343],"treatment-emergent":[344],"Grade":[345],"3/4":[346],"adverse":[347],"events,":[348],"regardless":[349],"attribution,":[351],"thrombocytopenia":[353],"(44%":[354],"42%":[357],"2),":[359],"anemia":[360],"(38%":[361,365],"50%),":[363],"neutropenia":[364,385,554,561],"38%),":[367],"fatigue":[368],"(16%":[369],"8%),":[371],"leukopenia":[372],"(13":[373],"4%)":[375],"pneumonia":[377],"(3%":[378,391],"12%).":[380],"incidence":[382,558],"febrile":[384,560],"low":[387],"cohorts":[390],"6%).":[393],"alone":[399,545,569],"LoDex":[402],"(See":[403],"table).":[404],"To":[405],"cohorts,":[409],"High":[412,466,596],"no":[416],"objective":[417],"responses":[418,607],"as":[419],"compared":[420,462],"Low":[424,451],"completed":[428],"durable":[434],"16%":[435,483],"overall":[436],"response":[437],"rate":[438],"(ORR)":[439],"8.6":[442],"month":[443],"(mo)":[444],"duration":[445],"response.":[447],"prolonged":[454],"OS":[455,610],"(median":[456],"=":[457,469],"23":[458],"mo)":[459],"observed":[461,500],"(OS":[468],"4.5":[470],"mo).":[471],"Follow-up":[472],"ongoing":[477],"ARRY-520+LoDex":[479],"ORR":[484],"date":[486],"this":[488,532],"very":[489],"heavily":[490],"pretreated":[491],"population.":[492],"Notably":[493],"4":[497],"PR":[498],"16":[503],"(25%)":[505],"who":[506],"previously":[508],"either":[511],"PI":[514,581],"(carfilzomib":[515],"MLN9708)":[517],"and/or":[518],"IMiD":[519],"(pomalidomide).":[520],"Conclusions":[521],"first-in":[526],"class":[527],"agent":[528],"analysis,":[535],"combination":[548,572],"LoDex.":[550,574],"While":[551],"transient":[552],"non-cumulative":[553],"observed,":[556],"low.":[563],"clear":[566],"Activity":[575],"IMiDs":[583],"suggests":[584],"lack":[586,604],"cross-resistance":[588],"existing":[592],"action.":[595],"associated":[601],"tumor":[606],"shorter":[609],"following":[611],"suggesting":[615],"may":[617],"be":[618],"potential":[620],"patient":[621],"selection":[622],"marker":[623],"identifying":[624],"unlikely":[626],"benefit":[628],"from":[629],"ARRY-520.":[630],"Disclosures:":[631],"Lonial:":[632],"Millennium:":[633],"Consultancy;":[634,636,638,640,642,726,728,733,743,745],"Novartis:":[635,696,738],"BMS:":[637],"Sanofi:":[639],"Onyx:":[641,727],"Celgene":[643,819],"Corporation:":[644,725,820],"Consultancy.":[645,731],"Off":[646],"Label":[647],"Use:":[648],"(Investigational":[650],"Drug).":[651],"Shah:Array":[652],"BioPharma:":[653,750,753,756,759],"Honoraria,":[654,668,683,697,711,763,775,791,806,821,836],"Membership":[655,669,684,698,712,764,776,792,807,822,837,850],"entity\u2019s":[658,672,687,701,715,767,779,795,810,825,840,853],"Board":[659,673,688,702,716,768,780,796,811,826,841,854],"Directors":[661,675,690,704,718,770,782,798,813,828,843,856],"advisory":[663,677,692,706,720,772,784,800,815,830,845,858],"committees,":[664,678,693,707,721,801,816,831,846],"Research":[665,679,694,708,722,736,740,747,787,802,817,832,847],"Funding;":[666,680,695,709,737,741,788,803,818,833,848],"Celgene:":[667,734],"Onyx":[681,789],"Pharmaceuticals:":[682,790,805],"Millenium:":[710,744],"Funding.":[723,748],"Zonder:Celgene":[724],"Skyline":[729],"Diagnostics:":[730],"Kaufman:Onyx:":[732],"Consultancy,":[735,739],"Janssen:":[742],"Merck:":[746,849],"Hilder:Array":[749],"Employment.":[751,754,757,760],"Rush:Array":[752],"Ptaszynski:Array":[755],"Walker:Array":[758],"Orlowski:Array":[761],"Biopharma:":[762],"committees;":[773,785],"Genentech:":[774],"Resverlogix:":[786],"Millenium":[804],"Bristol-Myers":[834],"Squibb:":[835],"committees.":[859]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":5}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}